Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
doi: https://doi.org/10.1101/2020.05.04.20090027
E Tuaillon
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
K Bolloré
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
A Pisoni
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
S Debiesse
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
C Renault
2Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS, Montpellier, France
S Marie
3Montpellier University Hospital, Montpellier, France
S Groc
3Montpellier University Hospital, Montpellier, France
C Niels
3Montpellier University Hospital, Montpellier, France
N Pansu
3Montpellier University Hospital, Montpellier, France
AM Dupuy
3Montpellier University Hospital, Montpellier, France
D Morquin
3Montpellier University Hospital, Montpellier, France
V Foulongne
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
A Bourdin
3Montpellier University Hospital, Montpellier, France
V Le Moing
3Montpellier University Hospital, Montpellier, France
P Van de Perre
1Pathogenesis and Control of Chronic Infections, University of Montpellier, INSERM, EFS; CHU Montpellier, Montpellier, France
Data Availability
Not available
Posted May 27, 2020.
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients
E Tuaillon, K Bolloré, A Pisoni, S Debiesse, C Renault, S Marie, S Groc, C Niels, N Pansu, AM Dupuy, D Morquin, V Foulongne, A Bourdin, V Le Moing, P Van de Perre
medRxiv 2020.05.04.20090027; doi: https://doi.org/10.1101/2020.05.04.20090027
Subject Area
Subject Areas
- Addiction Medicine (316)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2298)
- Dermatology (202)
- Emergency Medicine (371)
- Epidemiology (11623)
- Forensic Medicine (10)
- Gastroenterology (683)
- Genetic and Genomic Medicine (3629)
- Geriatric Medicine (341)
- Health Economics (622)
- Health Informatics (2332)
- Health Policy (919)
- Hematology (336)
- HIV/AIDS (758)
- Medical Education (361)
- Medical Ethics (101)
- Nephrology (394)
- Neurology (3390)
- Nursing (193)
- Nutrition (512)
- Oncology (1777)
- Ophthalmology (526)
- Orthopedics (211)
- Otolaryngology (284)
- Pain Medicine (226)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1013)
- Primary Care Research (410)
- Public and Global Health (6021)
- Radiology and Imaging (1238)
- Respiratory Medicine (814)
- Rheumatology (370)
- Sports Medicine (319)
- Surgery (390)
- Toxicology (50)
- Transplantation (171)
- Urology (143)